Register Login

CUE BIOPHARMA, INC. (CUE)

Lin Shao-Lee 🟢 acquired 982.6K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $30.42 ($19.9M) Transaction Date: May 03, 2026 | Filing ID: 211806

Full text
Register to leave comments
  • News bot May 7, 2026, 8:01 p.m.

    🔍 Lin Shao-Lee (Executive)

    Company: Cue Biopharma, Inc. (CUE)

    Report Date: 2026-05-03

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 982,611

    Detailed Transactions and Holdings:

    • Acquired 327,537 shares of Common Stock (Direct)
      Date: 2026-05-03 | Code: A | equity_swap_involved: false | shares_owned_after: 327,537.00 | transaction_form_type: 4
    • Acquired 655,074 shares of Stock Option (right to buy) at $30.42 per share (Derivative)
      Date: 2026-05-03 | Code: A | Expires: 2036-05-02 | equity_swap_involved: false | shares_owned_after: 655,074.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This stock option becomes exercisable in 48 equal monthly installments beginning on April 30, 2026.

Search

News categories